BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3485952)

  • 1. Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
    Foster NL; Chase TN; Patronas NJ; Gillespie MM; Fedio P
    Ann Neurol; 1986 Feb; 19(2):139-43. PubMed ID: 3485952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A neuropsychological and functional brain imaging study of visuo-imitative apraxia].
    Peigneux P; Van Der Linden M; Andres-Benito P; Sadzot B; Franck G; Salmon E
    Rev Neurol (Paris); 2000 May; 156(5):459-72. PubMed ID: 10844366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
    Zahn R; Juengling F; Bubrowski P; Jost E; Dykierek P; Talazko J; Huell M
    Psychiatry Res; 2004 Dec; 132(2):159-72. PubMed ID: 15598550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease.
    Kessler J; Mielke R; Grond M; Herholz K; Heiss WD
    Int J Neurosci; 2000; 104(1-4):1-15. PubMed ID: 11011970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease.
    Ober BA; Jagust WJ; Koss E; Delis DC; Friedland RP
    J Clin Exp Neuropsychol; 1991 Sep; 13(5):752-72. PubMed ID: 1955530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Slowly progressive apraxia: a MRI and positron tomography in 4 cases].
    Léger JM; Levasseur M; Benoit N; Baron JC; Tran Dinh S; Bolgert F; Cohen L; Brunet P; Signoret JL
    Rev Neurol (Paris); 1991; 147(3):183-91. PubMed ID: 2063064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety.
    Reivich M; Gur R; Alavi A
    Hum Neurobiol; 1983; 2(1):25-33. PubMed ID: 6603451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local cerebral glucose metabolic response to audiovisual stimulation and deprivation: studies in human subjects with positron CT.
    Mazziotta JC; Phelps ME; Halgren E
    Hum Neurobiol; 1983; 2(1):11-23. PubMed ID: 6603450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral metabolic effects of a verbal fluency test: a PET scan study.
    Parks RW; Loewenstein DA; Dodrill KL; Barker WW; Yoshii F; Chang JY; Emran A; Apicella A; Sheramata WA; Duara R
    J Clin Exp Neuropsychol; 1988 Oct; 10(5):565-75. PubMed ID: 3265709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual processing impairments and decrements in regional brain activity in Alzheimer's disease.
    van Rhijn SJ; Glosser G; de Vries JJ; Clark CM; Newberg AB; Alavi A
    J Clin Exp Neuropsychol; 2004 Feb; 26(1):11-23. PubMed ID: 14972690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP; Budinger TF; Koss E; Ober BA
    Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.